Join us at the 42nd Annual J.P. Morgan Healthcare Conference.
AGENDA:
8:00 - 9:00 am: Check In & Light Breakfast
9:00 - 9:30 am: Intro & Welcome with DHC Founder and CEO Anthony Davies, Ph.D. and DHC COO and Managing Partner Katy Spink, Ph.D.
9:30 - 10:30 am: Panel #1: Therapeutics Investment Outlook, hosted by Katy Spink
10:30 - 11:00 am: Break/Networking
11:00 - 12:00 pm: Panel #2: Tools, Tech & Services Market Outlook, hosted by Anthony Davies
12:00 am - 12:10 pm - Closing Remarks with Anthony Davies
12:10 - 1:00 pm - Networking Reception
Our distinguished panelists will include:
For Panel #1: Therapeutics Investment Outlook:
Khalil Barrage, Managing Director, Invus Public Equities
João Ribas, Principal, Seed Investments, Novo Holdings
Nandita Shangari, Managing Director, RA Capital Management
for Panel #2: Tools, Tech, & Services Market Outlook
Ruoxi Chen, Managing Director, Warburg Pincus
Edward de Nor, Partner, GHO Capital
Fabian Gerlinghaus, Co-Founder & CEO, Cellares
Sadik Kassim, CTO Genomic Medicines, Danaher Corporation
Joseph LaPlume, Corporate EVP, Corp Dev & Strategy, Charles River Laboratories
Alberto Santagostino, SVP, Head of Cell and Gene Technology, Lonza